Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays
- PMID: 15653641
- PMCID: PMC546166
- DOI: 10.1093/nar/gki188
Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays
Erratum in
- Nucleic Acids Res. 2005;33(8):2764. Lam, David CL [added]; Girard, L [added]; Wang, Elaine [added]; Chiu, SW [added]; Chung, Lap Ping [added]; Lam, WK [added]; Minna, John D [added]
Abstract
Gene transcription in a set of 49 human primary lung adenocarcinomas and 9 normal lung tissue samples was examined using Affymetrix GeneChip technology. A total of 3442 genes, called the set M AD, were found to be either up- or down-regulated by at least 2-fold between the two phenotypes. Genes assigned to a particular gene ontology term were found, in many cases, to be significantly unevenly distributed between the genes in and outside M AD. Terms that were overrepresented in M AD included functions directly implicated in the cancer cell metabolism. Based on their functional roles and expression profiles, genes in M AD were grouped into likely co-regulated gene sets. Highly conserved sequences in the 5 kb region upstream of the genes in these sets were identified with the motif discovery tool, MoDEL. Potential oncogenic transcription factors and their corresponding binding sites were identified in these conserved regions using the TRANSFAC 8.3 database. Several of the transcription factors identified in this study have been shown elsewhere to be involved in oncogenic processes. This study searched beyond phenotypic gene expression profiles in cancer cells, in order to identify the more important regulatory transcription factors that caused these aberrations in gene expression.
Figures
Similar articles
-
The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.Cancer Res. 2002 Sep 15;62(18):5273-9. Cancer Res. 2002. PMID: 12234996
-
Progressive lung cancer determined by expression profiling and transcriptional regulation.Int J Oncol. 2012 Jul;41(1):242-52. doi: 10.3892/ijo.2012.1421. Epub 2012 Mar 28. Int J Oncol. 2012. PMID: 22469662
-
Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.Oncol Rep. 2006 Sep;16(3):587-95. Oncol Rep. 2006. PMID: 16865260
-
Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network.BMC Syst Biol. 2008 May 22;2:46. doi: 10.1186/1752-0509-2-46. BMC Syst Biol. 2008. PMID: 18498649 Free PMC article.
-
Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.Oncogene. 2004 Feb 5;23(5):1166-76. doi: 10.1038/sj.onc.1207234. Oncogene. 2004. PMID: 14647414
Cited by
-
'N-of-1-pathways' unveils personal deregulated mechanisms from a single pair of RNA-Seq samples: towards precision medicine.J Am Med Inform Assoc. 2014 Nov-Dec;21(6):1015-25. doi: 10.1136/amiajnl-2013-002519. Epub 2014 Jun 12. J Am Med Inform Assoc. 2014. PMID: 25301808 Free PMC article.
-
Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer.PLoS One. 2012;7(8):e42086. doi: 10.1371/journal.pone.0042086. Epub 2012 Aug 2. PLoS One. 2012. PMID: 22876301 Free PMC article.
-
Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes.Genome Biol. 2020 Jun 9;21(1):127. doi: 10.1186/s13059-020-02035-x. Genome Biol. 2020. PMID: 32513296 Free PMC article.
-
Hidden treasures in "ancient" microarrays: gene-expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal tissue.Front Oncol. 2014 Sep 29;4:251. doi: 10.3389/fonc.2014.00251. eCollection 2014. Front Oncol. 2014. PMID: 25325012 Free PMC article.
-
Small interfering RNA against transcription factor STAT6 leads to increased cholesterol synthesis in lung cancer cell lines.PLoS One. 2011;6(12):e28509. doi: 10.1371/journal.pone.0028509. Epub 2011 Dec 5. PLoS One. 2011. PMID: 22162773 Free PMC article.
References
-
- Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 2000;100:57–70. - PubMed
-
- Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics, 2003. CA Cancer J. Clin. 2003;53:5–26. - PubMed
-
- Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., et al. The sequence of the human genome. Science. 2001;291:1304–1351. - PubMed
-
- Ramaswamy S., Golub T.R. DNA microarrays in clinical oncology. J. Clin. Oncol. 2002;20:1932–1941. - PubMed
-
- Geller S.C., Gregg J.P., Hagerman P., Rocke D.M. Transformation and normalization of oligonucleotide microarray data. Bioinformatics. 2003;19:1817–1823. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases